Mini Kapoor



Education and Clerkships

J.D., University of Houston Law Center, 2012, with honors; Associate Editor, Houston Law Review

Ph.D., Biochemistry and Molecular Biology, University of Kansas Medical Center, 1995

M.Sc., Biosciences, University of Roorkee, Roorkee, India, 1990

B.Sc., KLDAV College, Meerut University, Roorkee, India, 1988

  • Judicial Intern, Honorable Judge Vanessa Gilmore, Federal Court for the Southern District of Texas, January-May 2011


Texas, 2012

U.S. Patent and Trademark Office, 2014

Court Admissions

U.S. District Court for the Eastern District of Texas

U.S. District Court for the Southern District of Texas




Mini Kapoor is an associate in the Litigation Practice Group in the Houston office of Haynes and Boone, LLP.

Prior to becoming a lawyer, Mini worked for many years in genetics and genomics at The University of Texas M.D. Anderson Cancer Center, where she conducted research under several national grants. She has published many articles in peer-reviewed scientific journals and has presented frequently at scientific meetings and conferences in the United States and Europe.

Selected Client Representations

  • Represented a large corporate client in obtaining a favorable settlement in a breach of contract action involving defective lifeboats.
  • Represented a manufacturer of petrochemicals in a trade secret lawsuit and obtained a permanent injunction and a favorable settlement.
  • Represented a corporate client in obtaining a favorable settlement in a breach of contract action involving a services contract.
  • Experience in Environmental law: Assisted with analysis of environmental and legal issues arising from EPA enforcement action, including pre-enforcement review of administrative orders, costs of different strategic options and strengths of various defenses for large corporate client. Reviewed and analyzed documents for responding to EPA enforcement action, including requests for information for another large corporate client.
  • Prosecuted code violations and misdemeanors for the City of Houston Municipal Courts as a volunteer prosecutor.

Selected Publications and Speeches

  • "The Recent Federal Circuit Decision in Acorda Therapeutics v. Mylan Pharmaceuticals May Not be the Last Word on Jurisdiction in ANDA Cases," co-author with Paul Dietze, Haynes and Boone, LLP article, April 25, 2016.
  • "Circumstances Mandating a Commercial Marketing Notice by a Biosimilar Applicant Ripe for Guidance From the High Court," co-author with Scott Cunning, Houston Law Review, February 15, 2016.
  • “High Court Underscores the Significance of Patent Invalidity and Non-infringement Opinions,” co-author with Kyle Musgrove, Houston Lawyer, September/October 2015.
  • “High Court Addresses the Effect of Opinions on Charges of Inducement of Infringement,” co-author with Kyle Musgrove, The IP Beacon, August 3, 2015.
  • “Teva Will Increase Reliance On Experts In Patent Cases,” author, Law360, March 18, 2015.

Professional and Community Activities

  • Intellectual Property American Inn of Court
  • Leadership Council on Legal Diversity Pathfinder 2015
  • Leadership Council on Legal Diversity Mentor 2015
  • State Bar of Texas
  • Houston Bar Association
  • Defense Research Institute (DRI)
  • Registered to practice before U.S. Patent and Trademark Office
  • Houston Intellectual Property Law Organization

Technical Publications

  • Mutation of phosphoserine 389 affects p53 function in vivo. J Biol Chem 271:29380-5, 11/1996. 
  • Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc Natl Acad Sci U S A 95:2834-7, 3/1998. 
  • Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation. Oncogene 19:358-64, 1/2000. 
  • High metastatic potential in mice inheriting a targeted p53 missense mutation. Proc. Natl. Acad. Sci 97:4174-4179, 2000. 
  • A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Mol Cell 7:283-92, 2/2001. 
  • p53 and Fas ligand are required for psoralen and UVA-induced apoptosis in mouse epidermal cells. Cell Death Differ 9:549-60, 5/2002. 
  • A comparative analysis of data generated using two different target preparation methods for hybridization to high-density oligonucleotide microarrays. BMC Genomics 5:2, 1/2004. 
  • Biological validation of differentially expressed genes in chronic lymphocytic leukemia identified by applying multiple statistical methods to oligonucleotide microarrays. J Mol Diagn 7:337-45, 8/2005. 
  • Analysis of dose-response effects on gene expression data with comparison of two microarray platforms. Bioinformatics 21:3524-9, 9/2005. 
  • Global detection of molecular changes reveals concurrent alteration of several biological pathways in nonsmall cell lung cancer cells. Mol Genet Genomics 274:141-54, 9/2005. 
  • Application of protein lysate microarrays to molecular marker verification and quantification. Proteome Sci 3:9, 2005. 
  • Reproducibility of gene expression signature-based predictions in replicate experiments. Clin Cancer Res 12:1721-7, 3/2006. 
  • Effect of Sirolimus treatment on gene expression in renal transplant patients. World J. Surgery 30:1-10, 2006.

Email Disclaimer